NGNE – neurogene inc. (US:NASDAQ)
Stock Stats
News
Shareholders that Lost Money on Neurogene Inc. (NGNE) Should Contact Levi & Korsinsky About Securities Fraud Investigation - NGNE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Investors to Reach Out
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
Neurogene Inc. (NASDAQ: NGNE) had its price target raised by analysts at Stifel Nicolaus from $44.00 to $60.00. They now have a "buy" rating on the stock.
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $65.00 to $60.00. They now have an "outperform" rating on the stock.
Form SC 13G Neurogene Inc. Filed by: FMR LLC
Form 8-K Neurogene Inc. For: Nov 11
Form SC 13G Neurogene Inc. Filed by: Casdin Capital, LLC
Form 8-K Neurogene Inc. For: Nov 04
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.